The Chemours (CC) Earnings Analysis

The Chemours (CC) has no confirmed upcoming earnings date. Last quarter (2026-02-19) it missed with EPS 0.05 USD vs 0.0887 USD est (-43.6%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -6.68.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CC next report earnings?

No confirmed upcoming earnings date is currently scheduled for CC. This page updates as the calendar is published.

CC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-190.05 USD0.0887 USD-43.6%Miss
2025-11-060.2 USD0.24 USD-16.7%Miss
2025-02-180.11 USD0.1 USD+10%Beat
2024-11-040.4 USD0.32 USD+25%Beat
2024-08-010.38 USD0.57 USD-33.3%Miss

Beat rate: 2/5 (40%) over reported quarters with consensus data.

CC valuation and analyst view

Trailing P/E-6.68
Trailing EPS-2.7336 USD
Price / book12.76
Dividend yield1.92%
Market cap2.78B
Analyst consensusHold (9 buy / 10 hold / 1 sell)
Avg price target28.33 USD

Related research pages

Frequently asked questions

When is The Chemours (CC)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for CC. This page updates as the calendar is published.

Did CC beat earnings last quarter?

In its 2026-02-19 report, CC posted EPS of 0.05 USD versus a 0.0887 USD estimate — a miss of 43.6%.

What is CC's earnings track record?

Over the last 5 reported quarters with consensus data, CC beat estimates 2 times (40%).

What is CC's current P/E ratio and EPS?

CC trades at a trailing P/E of -6.68 on trailing EPS of -2.7335957137378837 USD.

What do analysts rate CC?

Analyst consensus is "Hold" across 20 ratings (0 strong buy, 9 buy, 10 hold, 1 sell, 0 strong sell). Average 12-month price target: 28.33 USD.